Blood, 122(21), 404-404. American Society of Hematology Scheid, C, Holt, B V D, Jarari, L E, Bertsch, U, Salwender, H, Zweegman, S, Vellenga, E, Broyl, A, Blau, I W, Weisel, K, Wittebol, S, Bos, G M J, Stevens, M, Schmidt-Wolf, I GH, Pfreundschuh, M, Hose, D, Jauch, A, Velde, H V D, Raymakers, R, Schaafsma, M R, Kersten, M J, Kooy, M V M, Duehrsen, U, Lindemann, H W, Wijermans, P W, Lokhorst, H & Goldschmidt, H 2013, ' Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial ', Blood, vol. 122, no. 21, pp. 404-404 . < http://www.mendeley.com/research/bortezomib-induction-maintenance-treatment-improves-survival-patients-newly-diagnosed-multiple-myelo >